Monopar Therapeutics Inc.

NASDAQ:MNPR

Biotechnology

Healthcare
$71.06 +2.45%

+$1.58 today

Market cap
$481.56M
Beta
1.54
P/E (TTM)
-37.6
EPS (TTM)
-$1.76
52W Low $29.18High $105.00

Volume 0.12M

Average 0.17M

Price history

Monopar Therapeutics Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-11.84%

Period high

$123.84

Period low

$50.12

Latest

$71.06

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 12, 2026Nov 12, 2026
10-QNov 12, 2026Nov 12, 2026
4Nov 4, 2026Nov 4, 2026
4Nov 4, 2026Nov 4, 2026
SC 13GOct 27, 2026Oct 27, 2026
4Oct 20, 2026Oct 20, 2026
4Oct 5, 2026Oct 5, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
4Sep 28, 2026Sep 28, 2026
4/AAug 28, 2026Aug 28, 2026
4/AAug 28, 2026Aug 28, 2026
4Aug 27, 2026Aug 27, 2026
4Aug 27, 2026Aug 27, 2026

Competitors

Who does Monopar Therapeutics Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about MNPR's filings, answered from its disclosures.

What is the latest MNPR filing?

The latest filing shown is 10-Q dated Nov 12, 2026.

How many recent filings does MNPR have?

Intrinsic Alpha currently shows 20 recent filings for MNPR.